MEK1/2 inhibitors block basal and transforming growth factor β1-stimulated JC virus multiplication

Journal of Virology

Volumn 81, Issue 12, 2007, Pages 6412-6418

  Ravichandran, Veerasamy ^a   Jensen, Peter N ^a   Major, Eugene O ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA BINDING PROTEIN; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PORTEIN KINASE KINASE 2 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN VP1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN CELL; JC VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIROGENESIS; VIRUS REPLICATION;

CELL LINE; CELL MEMBRANE; CELL NUCLEUS; CELLS, CULTURED; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; JC VIRUS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; SIGNAL TRANSDUCTION; STEM CELLS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; VIRUS REPLICATION;

JC POLYOMAVIRUS;

EID: 34249934653     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02658-06     Document Type: Article

References (32)

1. Alcorn, M. J., J. L. Booth, K. M. Coggeshall, and J. P. Metcalf. 2001. Adenovirus type 7 induces interleukin-8 production via activation of extracellular regulated kinase 1/2. J. Virol. 75:6450-6459.
2. Blenis, J. 1993. Signal transduction via the MAP kinases: proceed at your own RSK. Proc. Natl. Acad. Sci. USA 90:5889-5892.
3. Chen, Y. G., A. Hata, R. S. Lo, D. Wotton, Y. Shi, N. Pavletich, and J. Massague. 1998. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12:2144-2152.
4. Crews, C. M., and R. L. Erikson. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74:215-217.
5. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
6. Dhar, A., J. Gardner, K. Bergmann, L. Wu, and A. Ghorpade. 2006. Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J. Neurosci. Res. 83:1271-1280.
7. Enam, S., T. M. Sweet, S. Amini, K. Khalili, and L. Del Valle. 2004. Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch. Pathol. Lab. Med. 128:282-291.
8. Frisque, R. J., G. L. Bream, and M. T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51:458-469.
9. Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:211-218.
10. Giambartolomei, S., F. Covone, M. Levrero, and C. Balsano. 2001. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the hepatitis C virus (HCV) core protein. Oncogene 20:2606-2610.
11. Jacque, J. M., A. Mann, H. Enslen, N. Sharova, B. Brichacek, R. J. Davis, and M. Stevenson. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17:2607-2618.
12. Jensen, P. N., and E. O. Major. 2001. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the non-coding regulatory region. J. Neurovirol. 7:280-287.
13. Johnson, R. A., X. L. Ma, A. D. Yurochko, and E. S. Huang. 2001. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 82:493-497.
14. Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
15. Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49-139.
16. Lopez-Casillas, F., J. L. Wrana, and J. Massague. 1993. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73:1435-1444.
17. Luo, H., B. Yanagawa, J. Zhang, Z. Luo, M. Zhang, M. Esfandiarei, C. Carthy, J. E. Wilson, D. Yang, and B. M. McManus. 2002. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 76:3365-3373.
18. Major, E. O. 2001. Human polyomaviruses, p. 2175-2196. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
19. Massague, J., S. W. Blain, and R. S. Lo. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103:295-309.
20. Messam, C. A., J. Hou, R. M. Gronostajski, and E. O. Major. 2003. Lineage pathway of human brain progenitor cells identified by JC virus susceptibility. Ann. Neurol. 53:636-646.
21. Messam, C. A., and E. O. Major. 2000. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J. Neurovirol. 6(Suppl. 1):S90-S94.
22. Nathanson, N., R. Ahmed, F. Gonzalez-Scarano, D. E. Griffin, K. Holmes, F. Murphy, and H. Robinson. 2003. Viral pathogenesis. Lippincott Williams & Wilkins, Philadelphia, PA.
23. Planz, O., S. Pleschka, and S. Ludwig. 2001. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 75:4871-4877.
24. Pleschka, S., T. Wolff, C. Ehrhardt, G. Hobom, O. Planz, U. R. Rapp, and S. Ludwig. 2001. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305.
25. Querbes, W., A. Benmerah, D. Tosoni, P. P. Di Fiore, and W. J. Atwood. 2004. A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. J. Virol. 78:250-256.
26. Raj, G. V., and K. Khalili. 1995. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 213:283-291.
27. Ravichandran, V., B. F. Sabath, P. N. Jensen, S. A. Houff, and E. O. Major. 2006. Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J. Virol. 80:10506-10513.
28. Seth, P., F. Diaz, and E. O. Major. 2003. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy. J. Neurovirol. 9:236-246.
29. Sontag, E., S. Fedorov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75:887-897.
30. Wick, W., U. Naumann, and M. Weller. 2006. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr. Pharm. Des. 12:341-349.
31. Yang, X., and D. Gabuzda. 1999. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J. Virol. 73:3460-3466.
32. Yogo, Y., T. Kitamura, C. Sugimoto, T. Ueki, Y. Aso, K. Hara, and F. Taguchi. 1990. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J. Virol. 64:3139-3143.